Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New Anti-Aging cream pinorox® put to the test

NCT ID NCT07111156

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 06, 2026 · Updated 2 times

Summary

This study tests whether a cream called Pinorox® can safely improve facial signs of aging like wrinkles and fine lines. About 81 adults aged 35 to 55 will use the cream for a period and have their skin measured with special devices. The goal is to see if the cream makes skin smoother, firmer, and more even-toned.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

81 people

The number who actually took part.

Started

Oct 2025

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

35 to 55 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 1\) Age: 35 to 55 years (both inclusive) at the time of consent. 2) Sex: Adult male and female having Crow's feet area wrinkles, fine lines, facial dark spots. 3\) Females of childbearing potential should have a self-reported negative urine pregnancy test at the time of screening visit. 4\) Subjects should not have used any cosmetic, nutraceutical or therapeutic products for skin ageing in last 3 months. 5\) Subjects are not allowed to participate in any other study until this study is complete. 6\) Subjects must be willing and able to follow the study directions and to return for all specified visits with the product. 7\) Subjects must agree to record each use of the test products in the subject's diary card on daily basis. 8\) Subjects must agree to record medication use during the study Exclusion Criteria: * 1\) Subjects who are on steroids for last six months. 2) Subjects who have used any cosmetic, nutraceutical or therapeutic products for skin last three months. 3\) Subjects who are on product which contains kojic acid, glycolic acid, niacinamide, alpha arbutin, Vitamin C and other skin ageing product. 4\) Subjects with other dermatologic diseases whose presence or treatments could interfere with the assessment of study. 5\) Subjects that are pregnant and/or breastfeeding. 6) The subject has a known allergy or sensitivity to soaps, lotions, detergents, detanglers or fragrances. 7\) Subjects if do not agree to limit sun exposure to affected areas such as face during prolonged sun exposure. 8\) The subject has any other skin conditions i.e. cuts, scratches, ring worms, etc. which in the opinion of the Investigator, will interfere with the study results or will create undue risk for the subject. 9\) The subject has any of the conditions or factors that the Investigator believes may affect the response of the skin or the interpretation of the test results. 10\) The subject is currently taking or has taken any medication, which the Investigator believes may influence the interpretation of the data. 11\) Any other condition which could warrant exclusion from the study, as per the dermatologist's/investigator's discretion.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Facial sign of aging are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • NovoBliss Research Private Limited

    Ahmedabad, Gujarat, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.